Expert Interview
A Second Look: Investigating Intellia’s CRISPR therapy NTLA-2002 in development for the treatment of swelling attacks in hereditary angioedema (HAE).
Ticker(s): NTLAInstitution: Asthma Allergy Specialists
- Board-certified allergist and immunologist with Asthma Allergy Specialists.
- Currently manages 35 patients with Hereditary Angioedema.
- Specializes in conditions such as Atopic dermatitis, Hereditary angioedema (HAE), Chronic spontaneous urticaria(CSU), Asthma/COPD, Systemic Mastocytosis, Eosinophilic Esophagitis, and Food allergies.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
